A research team from Bellvitge Campus of the University of Barcelona (UB) and Bellvitge Biomedical Research Institute (IDIBELL) made a significant advance in the knowledge of the molecular mechanism that reprograms the cell in the tumour formation process. The new study, published in the journal iScience, is led by Professor Albert Tauler, from the Department of Biochemistry and Physiology of the Faculty of Pharmacy and Food Sciences of the UB.

More